3rd Quarter - Report

OGR for AMGEN USA INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
OGR
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 20, 2008 $30,000 Replaced
3rd Quarter - Amendment Oct 20, 2008 $30,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Coverage and Reimbursement issues.

LobbyistCovered position, as disclosed
DEAN AGUILLEN Advr, Pelosi; Dir Intgvt Aff, Labor; LA, Sandlin
ANDREW ROSENBERG New Leg Asst, Kennedy; Leg Aide, Sen HELP Comm

Contacted: HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R.1956, The Patient Protection and Innovative Biologic Medicines Act. FDA related issues.

LobbyistCovered position, as disclosed
DEAN AGUILLEN Advr, Pelosi; Dir Intgvt Aff, Labor; LA, Sandlin
ANDREW ROSENBERG New Leg Asst, Kennedy; Leg Aide, Sen HELP Comm

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 1956 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.